Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control studyJan Menne, Cay Uwe von Seydewitz, Veit Busch et al.|BMJ|2012Cited by 309
Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registryJan T. Kielstein, R. Brunkhorst, Gernot Beutel et al.|Nephrology Dialysis Transplantation|2012Cited by 239
Characteristics of hypotension-prone haemodialysis patients: is there a critical relative blood volume?Cláudia Barth, Jutta Passlick‐Deetjen, Walther H. Boer et al.|Nephrology Dialysis Transplantation|2003Cited by 122
Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugsClaudia Stefanutti, Elda Favari, Ulrich Julius et al.|Journal of clinical lipidology|2017Cited by 119